Clinical Trial Update: Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry

View source ↗

Summary

A completed real-world registry in Brazil evaluating outcomes of the Xience V everolimus-eluting coronary stent system in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• XIENCE V Everolimus Eluting Coronary Stent System (Everolimus-eluting coronary stent)

Snippet

Sponsor: Cardiovascular Research Center, Brazil | Conditions: Arterial Coronary Disease | Status: COMPLETED